Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galenika A.D.filedCriticalGalenika A.D.
Priority to YU14403ApriorityCriticalpatent/YU14403A/sh
Publication of YU14403ApublicationCriticalpatent/YU14403A/sh
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Pronalazak odnosi se na novi metod i primeni 2-Гџ-D-ribofuranoziltiazol-4-karboksamida i njegovih derivata, pre svega 5'-O-estra, za proizvodnju farmaceutskih proizvoda za lečenje i preventivu sistemskih autoimunskih bolesti, prvenstveno multiple skleroze.[The invention relates to both the new method and the use of 2-Гџ-D-ribofuranosylthiazole-4 carboxiamide and derivatives thereof, primarily 5'-O-esters, for production of pharmaceutical products for healing and prevention of systemic autoimmune disorders, primarily multiplex sclerosis.
YU14403A2003-02-252003-02-25Nova primena jedinjenja
YU14403A
(sh)
Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof